Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
645.00    -34.00 (-5.01%)
Bid:
643.00
Ask:
645.00
Spread: 2.00 (0.311%)
Market Cap: £1.18b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Interim Management Statement

9 Feb 2010 07:00

RNS Number : 8500G
Volex Group PLC
09 February 2010
Β 

Β 

9 February 2010

Β 

VOLEX GROUP plc

Β Interim Management Statement for the 18 weeks ended 9 February 2010

Β Volex Group plc, the global electrical and electronic cable assemblies group, today releases its second Interim Management Statement for the FY2010 financial year, covering the 18 weeks ended 9 February 2010.

As indicated in the trading update released on 12 January 2010 group revenue has continued to trend upwards quarter-on-quarter, driven by strength in the consumer focused Power Products sector, which is starting to see improved OEM demand, while Interconnect remains adversely impacted by industry conditions and delayed network rollout, principally in India and China.

Favourable commodity prices and ongoing progress in the cost saving programmes has delivered further modest quarter-on-quarter improvements in gross margins, while the improvement in year-on-year gross margins is more substantial. Importantly, with initiatives underway to align the Group's manufacturing capacity and support facilities more closely with its customer base and market environment, the Group expects to be well positioned to capitalise on a more sustained economic recovery, as and when it occurs.

Β Highlights for the third quarter of FY2010 (three months to 3 Jan 2010) are as follows:

Β·; Revenue from continuing operations of Β£58m, up 3% on Q2 FY2010 (down 11% on same period last year, at constant currency)

Β·; Gross margin of 21.4%, 1.3pts up on H1FY2010 and 6.4pts ahead of same period last year

Β·; Operating profit(i) from continuing operations of Β£3.4m, up 9% on Q2 FY2010Β (up 10% on same period last year, at constant currency)

Β·; Net debt of Β£11.3m held at half year level, compared with Β£23.0m at the same point last year

Β (i) before non-recurring items and share based payments

Β 

Power Products revenue in the third quarter of Β£37m was 5% up on Q2. Although down compared to the third quarter of last year (down 2% at constant currency), performance relative to last year is on an improving path as OEM demand improves. Much of the improvement in trading has been driven by strong sales in Asian markets as our customers continue to migrate their manufacturing capability east. Power Products gross margin in the third quarter increased to 23.4% from 21.1% in the first half due to manufacturing efficiencies and a favourable impact from commodity prices. As a result third quarter operating profit was 22% up on the second quarter and 90% up on the third quarter of last year, at constant currency.

Interconnect revenues in the third quarter were flat on Q2 and 23% down (at constant currency) on the third quarter of last year, as our telecoms customers, particularly in Europe and North America continued to face challenging market conditions with delayed network infrastructure rollouts in China and India. Trading in the Healthcare sector (approximately 30% of total Interconnect) has fared better, with Healthcare revenue in the third quarter showing a modest improvement over Q2. Although Interconnect gross margins in Q3 decreased slightly to 18.1% from 18.6% in the first half of the year, they remained well ahead of last year.Β 

The Group continued to manage its cash and borrowings effectively with net debt at the end of the third quarter of Β£11.3m in line with management's expectations, ahead of traditionally strong cash generation in the fourth quarter.

As communicated in the trading update released on 12 January 2010, the Board remains cautious on the company's short term prospects in the face of continued global economic uncertainties. However, as further noted in that announcement, the Board is comfortable that the company will meet or exceed the previous full year guidance on the trading outlook for the twelve months to 4th April 2010.Β 

Β 

- END -

Β 

Volex Group plc

Ray Walsh, Group Chief Executive +44 20 3370 8833 Andrew Cherry, Group Finance Director +44 20 3370 8833

Β 

Weber Shandwick Financial

Terry Garrett / Nick Dibden / Katie Matthews +44 20 7067 0700

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSSSAFWAFSSEEE
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.